Name:  ___         Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Chief complaint: Obesity for the last ___ years without sustained
weight loss after organized attempts.  

History of present illness: This is a ___ woman with a
history of morbid obesity that is resistant to diet and exercise
who presents for evaluation for weight loss surgery. 

The patient has struggled with excess weight since she was
approximately ___ years old. Her peak weight was 350 pounds. She
currently weighs 342.1 pounds with a BMI of 53.6. She attributes
her weight to high fat, high carbohydrate snacks, grazing, as
well as emotional eating. She has tried to lose weight in the
past and lost as much as 20 pounds but was unable to keep the
weight off. She has tried ___, ___ and Weight 
Watchers
nutrition plans to lose weight without lasting effect. In terms
of exercise she walks ___ times per week for 30 minutes when the
weather permits. She has no history of eating disorders. She has
had depressed mood in the past but never taken psychotropic
medications or been hospitalized. 

In terms of weigh-related comorbidities she does endorse
hypertension, knee pain with movement, and pre-diabetes with
hemoglobin A1c of 6.1%. She denies sleep apnea, pain with
activity, and esophageal reflux.

Of note the patient has a history of umbilical hernia repair in
___. The patient was booked for laparoscopic umbilical hernia
repair. During the case, the patient developed profound
hypotension and there was concern for intra-abdominal injury so
an exploratory laparotomy was performed and the bowel and
recesses were negative for evidence of injury or hemorrhage. The
hernia was then repaired without mesh in an open fashion and her
abdomen was closed with PDS. Intra-abdominal adhesions were not
commented on in the operative report (The patient had previously
received a laparoscopic cholecystectomy).

She denies chest pain, shortness of breath, nausea, abdominal
pain, extremity pain, and any other meical complaints. 

Review of symptoms: 14 point review of symptoms is negative
except that noted above. 

 
Past Medical History:
hypertension
migraines
endometrial polyps
dysmenorrhea
low back pain
vitamin D deficiency
iron deficiency
positive PPD
pleomorphic adenoma
umbilical hernia and rectus sheath diastasis
pre-diabetes (hemoglobin A1c 6.1%)

 
Social History:
___
Family History:
non-contributory

 
Physical Exam:
VS: ___ 0703 Temp: 98.2 PO BP: 132/85 HR: 79 RR: 18 O2 sat:
96% O2 delivery: Ra 
Gen: well appearing in NAD
HEENT: NCAT, PERRLA, sclera anicteric, MMM, oropharynx clear
CV: RRR, no m/r/g
PULM: no respiratory distress, CTAB bilaterally, no wheezing,
rales or ronchi
ABD: soft, appropriate trace ___ tenderness, no
rebound or guarding. incisions healing well, steris in place,
c/d/i
Ext: WWP, no edema

 
Pertinent Results:
___ 07:54PM BLOOD Hct-40.7
___ 04:17AM BLOOD Hct-38.4
 
Brief Hospital Course:
The patient presented to pre-op on ___. Pre-operatively, 
patient reports r leg pain, and ___ venous duplex US did not 
show evidence of DVT. Plan was then to proceed with surgery. 
Patient was evaluated by anaesthesia.  
 The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.   
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  
 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored. Patient was 
started on amlodipine 2.5 mg PO for blood pressure control, as 
her home nefedipine was non-crushable. BP was well controlled, 
thus home chlorthalidone was held.
 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  
 GI/GU/FEN: The patient was initially kept NPO. On POD 1, 
patient underwent UGI study, which showed no obstruction or 
leak. Afterwards, the patient was started on a stage 1 bariatric 
diet, which the patient tolerated well. Subsequently, the 
patient was advanced to stage 2, and then stage 3 diet which the 
patient was tolerating on day of discharge.  
 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  
 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  
 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  
 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. NIFEdipine (Extended Release) 60 mg PO DAILY 
2. Ferrous Sulfate unknown  PO DAILY 
3. pediatric multivitamin ___ tablets oral DAILY 
4. Sumatriptan Succinate 50 mg PO ASDIR 
5. Chlorthalidone 25 mg PO DAILY 
6. Vitamin D unknown  PO DAILY 
7. Naproxen 500 mg PO Q12H:PRN Pain - Moderate 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Mild 
RX *acetaminophen 650 mg/20.3 mL 20 ml by mouth every six (6) 
hours Disp #*300 Milliliter Refills:*0 
2.  amLODIPine 2.5 mg PO DAILY 
Please crush 
RX *amlodipine 2.5 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0 
3.  Docusate Sodium 100 mg PO BID:PRN constipation 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day Disp 
___ Milliliter Milliliter Refills:*0 
4.  Famotidine 20 mg PO BID 
Please crush 
RX *famotidine 20 mg 1 tablet(s) by mouth twice a day Disp #*60 
Tablet Refills:*0 
5.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours Disp 
___ Milliliter Refills:*0 
6.  SUMAtriptan 20 mg/actuation nasal DAILY:PRN 
RX *sumatriptan 20 mg 1 daily Disp #*5 Spray Refills:*0 
7.  Ferrous Sulfate unknown  PO DAILY 
Please crush  
8.  pediatric multivitamin ___ tablets oral DAILY 
Please crush  
9.  Vitamin D unknown  PO DAILY 
Please crush  
10. HELD- Chlorthalidone 25 mg PO DAILY  This medication was 
held. Do not restart Chlorthalidone until you discuss with Dr. 
___ your PCP.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear ___,

You were on nifedipine extended release at home, but this 
medication cannot be crushed. It is being replaced with 
amlodipine 2.5mg PO daily, and your blood pressure responded 
well to the medication. We're also holding your home 
chlorthalidone because your blood pressure is well controlled on 
just the amlodipine. Please follow up with your primary care 
doctor regarding any adjustments in your blood pressure 
medications.

You have undergone a laparoscopic sleeve gastrectomy, recovered 
in the hospital and are now preparing for discharge to home with 
the following instructions:

Please call your surgeon or return to the Emergency Department 
if you develop a fever greater than ___ F, shaking chills, chest 
pain, difficulty breathing, pain with breathing, cough, a rapid 
heartbeat, dizziness, severe abdominal pain, pain unrelieved by 
your pain medication, a change in the nature or severity of your 
pain, severe nausea, vomiting, abdominal bloating, severe 
diarrhea, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness, swelling from your 
incisions, or any other symptoms which are concerning to you.
Diet: Stay on Stage III diet until your follow up appointment; 
please refer to your work book for detailed instructions. Do not 
self- advance your diet and avoid drinking with a straw or 
chewing gum. To avoid dehydration, remember to sip small amounts 
of fluid frequently throughout the day to reach a goal of 
approximately ___ mL per day. Please note the following signs 
of dehydration: dry mouth, rapid heartbeat, feeling dizzy or 
faint, dark colored urine, infrequent urination. 

Medication Instructions:
Please refer to the medication list provided with your discharge 
paperwork for detailed instruction regarding your home and newly 
prescribed medications.  
Some of the new medications you will be taking include:
1.  Pain medication: You will receive a prescription for liquid 
oxycodone, an opioid pain medication.  This medication will make 
you drowsy and impair your ability to drive a motor vehicle or 
operate machinery safely. You MUST refrain from such activities 
while taking these medications. You may also take acetaminophen 
(Tylenol) for pain management; do not exceed 4000 mg per 24 hour 
period.
2. Constipation: This is a common side effect of opioid pain 
medication.  If you experience constipation, please reduce or 
eliminate opioid pain medication.  You may trial 2 ounces of 
light prune juice and/or a stool softener (i.e. crushed docusate 
sodium tablets), twice daily until you resume a normal bowel 
pattern.  Please stop taking this medication if you develop 
loose stools. Please do not begin taking laxatives including 
until you have discussed it with your nurse or surgeon.
3. Antacids: You will be taking famotidine tablets, 20 mg twice 
daily, for one month. This medicine reduces stomach acid 
production. Please crush.
4. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs). Examples include, but are not limited to Aleve, 
Arthrotec, aspirin, Bufferin, diclofenac, Ecotrin, etodolac, 
ibuprofen, Indocin, indomethacin, Feldene, ketorolac, 
meclofenamate, meloxicam, Midol, Motrin, nambumetone, Naprosyn, 
Naproxen, Nuprin, oxaprozin, Piroxicam, Relafen, Toradol and 
Voltaren. These agents may cause bleeding and ulcers in your 
digestive system. If you are unclear whether a medication is 
considered an NSAID, please ask call your nurse or ask your 
pharmacist.
5.  Vitamins/ minerals: You may resume a chewable multivitamin, 
however, please discuss when to resume additional vitamin and 
mineral supplements with your bariatric dietitian.

Activity:
You should continue walking frequently throughout the day right 
after surgery; you may climb stairs.  
You may resume moderate exercise at your discretion, but avoid 
performing abdominal exercises or lifting items greater than10 
to 15 pounds for six weeks.

Wound Care:
You may remove any remaining gauze from over your incisions.  
You will have thin paper strips (Steri-Strips) over your 
incision; please, remove any remaining Steri-Strip seven to 10 
days after surgery.   
You may shower 48 hours following your surgery; avoid scrubbing 
your incisions and gently pat them dry.  Avoid tub baths or 
swimming until cleared by your surgeon. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Please call the doctor if you have increased pain, swelling, 
redness, cloudy, bloody or foul smelling drainage from the 
incision sites. 
Avoid direct sun exposure to the incision area for up to 24 
months.
Do not use any ointments on the incision unless you were told 
otherwise.

 
Followup Instructions:
___